2025-2032 年全球基因改造作物农业生物技术市场预测（按性状类型、作物类型、应用和最终用户划分）

预计到 2032 年，基改作物的农业生技市场规模将成长至 337 亿美元，复合年增长率为 19.14%。

主要市场统计数据
基准年2024年	82.9亿美元
预计2025年	98.9亿美元
预测年份：2032年	337亿美元
复合年增长率（%）	19.14%

在技​​术进步、监管变化和整个农业价值链相关人员的期望下，制定生物技术作物部署的战略背景

随着基改作物从利基创新领域逐渐发展成为具有韧性的农业粮食系统的核心组成部分，农业生物技术领域正在经历关键性的变革。性状工程的发展，加上法律规范的演变和贸易动态的变化，正在重塑从种子开发者到农民再到政策制定者等相关人员对作物改良的处理方式。本引言概述了影响基改作物发展的多维力量，并将后续分析置于研究流程、供应链整合和市场发展的现实背景中。

过去十年，精准育种技术和改良的性状迭加技术提升了针对耐旱性、耐除草剂性和抗虫性的基因改造解决方案的技术可行性和商业性吸引力。同时，终端用户对稳定产量、降低投入成本和降低环境风险的需求，使得人们更加关注那些能够带来明显农艺和经济效益的性状。因此，价值链上的组织正在重新调整其优先事项，并将研发投资与已在田间验证的性状结合。

本报告首先概述了基因改造作物推广的策略背景及其对关键相关人员的营运影响。透过综合科学趋势、监管讯号和市场行为，本引言将帮助读者理解后续的深入分析，并确定投资和政策选择最关键的策略曲折点。

快速的技术创新、不断发展的法律规范和不断变化的商业性重点如何重新定义基改作物开发的价值创造和竞争定位

基因改造作物格局正在发生变化，改变了竞争格局、投资重点和应用途径。基因编辑、性状迭加和高通量表型分析技术的进步正在加速可操作性状从概念到田间试验的转化。因此，那些将分子创新与实用育种策略和可靠的田间检验相结合的公司正在获得战略优势。这种技术动能与种苗公司营运的成熟度相得益彰，他们将独特性状与强化种子处理和数位农学相结合，为农场带来显着的价值。

同时，法律规范也不断发展，以适应新型生物技术的发展，同时兼顾大众接受度和生物安全问题。一些司法管辖区简化了某些基因编辑计画的核准流程，加快了其商业化进程，促使全球重新思考发展策略。即便如此，监管多样性依然存在，企业必须设计出合规且足够灵活的产品系列，以满足各主要市场不同的核准要求。

随着下游相关人员（例如加工商、食品和饲料公司以及农民）评估基因改造技术的经济和永续性影响，市场接受度也在改变。人们对抗逆力的日益关注，使得耐旱性等特性的重要性日益凸显，而病虫害综合治理的优先性则继续支撑着抗虫创新。总而言之，这些转型变革正在重新定义基因改造生态系统中价值创造和取得的领域，凸显了跨职能策略的必要性，该策略将科学、监管事务和商业性执行融为一体。

了解2025年关税政策变化对基改作物供应链研究合作和农场决策的更广泛的商业性和管理影响

2025年之前宣布并实施的关税政策变化的累积效应，带来了供应商和买家无法忽视的商业性复杂性。关税调整会影响整个国际供应链中交易农产品、种子投入和性状的成本计算。对于跨国开发商而言，关税波动使生产阶段、田间试验和库存位置的决策变得复杂，从而影响到在以出口为重点的作物领域保持竞争力所必需的定价策略。

贸易紧张局势也对研发合作产生间接影响。当种质资源、生物材料和专用设备的跨境交换变得更加昂贵或行政负担加重时，计划週期就会延长，贸易摩擦也会加剧。在此背景下，企业正在重新调整伙伴关係模式，优先选择区域育种和规模化生产中心，以降低关税带来的成本衝击，同时维持对重要种质资源库的取得。

从农民和加工商的角度来看，关税导致的投入和商品经济变化可能会改变作物轮作和管理选择，从而影响基因改造需求。例如，玉米、大豆、棉花和油菜籽进出口奖励的变化可能会改变生产者的风险回报计算，并加速或延缓某些基因改造特性的采用。因此，政策制定者和产业领导者必须考虑关税的直接影响，以及可能再形成全部区域基因改造采用模式的一系列行为反应。

利用细緻的转化作物应用和最终用户细分，使研究重点与商业化策略和相关人员参与基因改造作物倡议保持一致

有效的细分主导方法可以揭示技术进步和商业性需求的交汇点，从而创造差异化机会。基于性状类型，耐旱性、耐除草剂性和抗虫性被强调为近期采用的关键载体，每种性状都具有独特的农艺效益并影响育种重点。基于作物类型，油菜、棉花、玉米和大豆表现出作物特异性途径，具有显着不同的性状价值提案、调控途径和种子系统动态。基于最终用途，生质燃料、食品和饲料、药品和加工应用定义了最终市场要求和品质阈值，从而决定了性状选择、管理期望和可追溯性需求。基于最终用户，生态系统由生物技术公司、企业概况、政府机构、研究机构和种苗公司组成，每家公司都对商业化时间表、责任概况和采用奖励施加独特的压力。

从策略角度解读市场细分，我们发现以性状为中心的投资必须与作物经济效益和应用需求紧密结合。由于气候变迁威胁产量稳定性，抗旱性具有重要的战略意义，而除草剂抗性和抗虫性则继续支持营运效率和病虫害管理策略。由于作物本身的限制和加工要求，千篇一律的性状开发方法不太可能带来永续的效益。相反，将性状创新与种子性能、管理框架和供应链保障相结合的综合项目更有可能实现更广泛的应用。

此外，终端用户的多样性凸显了跨部门合作的必要性。成功的应用取决于能否让农民参与检验在现实环境中的农艺效益，与种苗公司协调分销和管理，与研究机构合作进行长期性状改良，以及与政府机构合作以确保监管协调和公众信任。基于此类细分层次洞察，制定研发和商业化规划，可以帮助组织更好地分配资源，并针对对应用至关重要的相关人员订做讯息。

了解美洲、欧洲、中东和非洲以及亚太地区的商业机会和监管现实，以优化性状开发和打入市场策略

区域动态在塑造基因改造作物推广轨迹和产业参与者的管理选择方面发挥着至关重要的作用。美洲拥有一体化的价值链、强大的私营育种能力以及对基因改造技术的广泛农场，为快速迭代和商业性规模化提供了有利条件。这种环境支持进行性状组合实验，并允许商业营业单位在不同农业生态学区域检验农艺性状。

欧洲、中东和非洲：欧洲、中东和非洲的监管和社会环境更为复杂，公众认知、多样化的监管方式以及参差不齐的基础架构层，使得制定差异化战略成为可能。在该地区的一些司法管辖区，严格的监管要求和日益严格的相关人员审查，使得采取审慎的、注重透明度的策略成为必要。同时，非洲和中东部分地区为开发商提供了战略机会，使他们能够利用自身特质，应对气候变迁并解决资源限制问题，前提是他们能够投资于公众参与和能力建设。

亚太地区提供了广泛的应用场景，从高度商业化的种植系统到以小农户为主的种植模式。法规环境和消费者偏好差异巨大，影响产品的接受度、管理模式和伙伴关係结构。在该地区经营的私人公司越来越多地寻求本地化的育种计画和官民合作关係，以确保基因改造性状既能满足大规模的商品需求，又能应对本地化的作物挑战。任何地区的成功都取决于根据当地监管现状、供应链结构和相关人员的期望制定合适的策略。

检验综合研发伙伴关係伙伴关係和卓越营运如何决定基因改造作物开发生态系统中的竞争优势

基因改造作物领域的竞争力取决于科学研究能力、监管专业知识和商业性可行性的结合。领先的机构透过管理整个创新生命週期（从发现和分子表征，到多地点田间检验、监管申报和商业性种子繁殖）来脱颖而出。伙伴关係、授权协议和收购仍然是扩大性状组合和加快上市时间的重要槓桿。

成功的公司在专有性状开发、管理和供应链完整性方面展现出实力。这些公司投资于数据主导的农艺服务、农民培训计画和转化后监测，以保持转化效果并管理抗性风险。将分子研发与实践推广和商业性支援相结合的公司，更有能力实现持续应用，并降低声誉和监管风险。

研究机构和公共部门参与者将继续发挥关键作用，尤其是在早期发现以及优先考虑公共产品（例如小农农业系统的抗旱能力）的情况下。将私部门的规模与公共部门的合法性结合的合作模式，可以加速科技的应用，同时解决社会关切。整体而言，竞争格局有利于垂直整合能力、协作敏捷性以及严谨的监管和管理义务履行方式。

采取策略行动，同步性状开发监管准备、供应链弹性和管理工作，确保负责任且可扩展地部署生物技术作物。

产业领导者应采取一系列切实可行的行动，将科学前景转化为商业性韧性和社会价值。首先，应将性状开发蓝图与作物特定的农艺现实和终端市场需求相结合，优先考虑那些在气候变迁下能够带来可衡量的农场效益和韧性的性状。其次，应透过投资模组化资料包、灵活的试验设计以及积极与监管机构和民间社会相关人员互动，制定能够预测不同司法管辖区差异的监管策略。

第三，我们将透过建立区域育种中心、区域种子繁殖能力和冗余物流来增强供应链的韧性，以缓解关税和贸易中断。第四，我们将致力于实施强有力的管理项目，将抗药性管理、农民培训和上市后监测相结合，以维护性状效力和公众信任。第五，我们将推行共同研究模式，将公共研究优势与私部门商业化能力结合，以因应小农户面临的挑战并提升社会合法性。

最后，投资透明的传播策略，清楚阐明基因改造解决方案的农艺、环境和经济原理，同时公开讨论安全和管理问题。透过协同实施这些行动，领导者可以减少商业化摩擦，在适当的情况下促进采用，并使基改作物创新与更广泛的永续性和粮食安全目标保持一致。

调查方法整合了主要专家访谈、二手文献监管审查和价值链分析，以确保得出严谨、基于证据的结论

本研究整合了同行评审的科学文献、监管文件、公共文件以及与专家相关人员的初步定性访谈，以建立坚实可靠的分析基础。调查方法强调跨多个资料来源的三角测量，并透过专家咨询进行检验，以确保解读既能反映技术现状，又能应对商业性限制。研究还审查了实地试验报告、专利态势和科学会议披露的信息，以评估关键性状类别的成熟度并识别新兴技术能力。

初步研究包括对高级研发领导、监管专家、种苗公司高管和学术研究人员的结构化访谈，以了解关于采用障碍、管理实践以及对贸易动态的战略响应的不同观点。二次研究涵盖监管沟通、产业协会声明以及广泛接受的科学综合，以巩固初步研究结果。本研究采用的分析框架，包括价值链图谱绘製、相关人员分析和基于情境的影响分析，探讨了关税变化和区域监管差异等变数如何影响策略选择。

在整个调查方法中，我们非常重视方法的透明度，并记录了定性推论所依据的假设。对于仍存在不确定性的情况，分析强调考虑突发事件，并建议进行有针对性的后续研究，以加深对基因编辑政策和跨国种质流动等快速发展领域的理解。

关于将科学创新与监管管理和相关人员参与相结合以负责任地发挥基因改造作物潜力的结论摘要

摘要，基改作物技术正处于一个策略曲折点，科学能力、不断发展的法规和商业性需求在此交会。未来的发展需要整合策略，将转化与作物的具体情况、应用需求和最终用户的期望结合。虽然技术进步降低了宝贵性状开发的技术壁垒，但监管制度的差异性和近期贸易政策的变化使营运环境更加复杂，需要製定适应性的商业化蓝图。

成功的组织将卓越的科学技术与切合实际的监管规划、富有弹性的供应链设计和透明的管理相结合。跨部门合作对于解决社会关切、加速适应性育种以应对气候变迁压力以及确保多样化农业系统受益仍然至关重要。最终，基改作物负责任的推广取决于将创新与明确的农艺价值、监管合规性和相关人员的信任相结合，从而确保这些技术能够对永续农业成果做出有意义的贡献。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

• 整合RNA干扰技术进行棉花害虫标靶防治
• 采用具有多重抗性特征的耐除草剂大豆品系进行杂草管理。
• 富含维生素原A的生物强化稻米品种的商业化，以对抗营养不良
• 基因驱动系统在主要作物入侵虫族群控制的应用
• 引入Glyphosate和草铵膦双重抗性的菜籽品係以提高产量稳定性
• 引进次世代定序，用于新型基改作物的监管核准

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 农业生物技术市场（基因改造作物类型）

• 耐旱性
• 除草剂抗性
• 抗虫性

9. 农业生物技术市场（基因改造作物，依作物类型）

• 菜籽
• 棉布
• 玉米
• 大豆

10. 农业生物技术市场（基因改造作物，依应用）

• 生质燃料
• 食品和饲料
• 製药
• 流程

11. 农业生物技术市场（基因改造作物）的最终用户

• 生技公司
• 农民
• 政府机构
• 研究机构
• 种子公司

12. 农业生物技术市场（基因改造作物）地区作物

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

13. 农业生物技术市场（基因改造作物）依类别

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

14. 各国基改作物农业生物技术市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章竞争格局

• 2024年市占率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • Bayer AG
  • Corteva, Inc.
  • Syngenta AG
  • BASF SE
  • KWS SAAT SE & Co. KGaA
  • Groupe Limagrain
  • Land O'Lakes, Inc.
  • Bioceres Crop Solutions Corp
  • Arcadia Biosciences, Inc.
  • Evogene Ltd

The Agricultural Biotechnology for Transgenic Crops Market is projected to grow by USD 33.70 billion at a CAGR of 19.14% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 8.29 billion
Estimated Year [2025]	USD 9.89 billion
Forecast Year [2032]	USD 33.70 billion
CAGR (%)	19.14%

Framing the strategic context for transgenic crop deployment amid technological advances regulatory shifts and stakeholder expectations across agricultural value chains

The agricultural biotechnology landscape is undergoing a pivotal transformation as transgenic crops move from niche innovations to core components of resilient agrifood systems. Advances in trait engineering, combined with evolving regulatory frameworks and shifting trade dynamics, are reshaping how stakeholders - from seed developers to farmers and policy makers - approach crop improvement. This introduction frames the multidimensional forces influencing transgenic crop development, situating the subsequent analysis within the practical realities of research pipelines, supply chain integration, and market acceptance.

Over the past decade, precision breeding techniques and improved trait stacking have increased both the technical feasibility and the commercial attractiveness of transgenic solutions targeting drought tolerance, herbicide tolerance, and insect resistance. At the same time, end-user demands for stable yields, reduced input costs, and environmental risk mitigation have sharpened the focus on traits that deliver clear agronomic and economic benefits. Consequently, organizations across the value chain are recalibrating priorities, aligning R&D investments with traits that demonstrate field-proven outcomes.

This report opens by outlining the strategic context for transgenic crop deployment and the operational implications for key stakeholders. By synthesizing scientific trends, regulatory signals, and market behaviors, the introduction prepares readers to interpret the deeper analyses that follow and to identify strategic inflection points where investment and policy choices will matter most.

How rapid technological innovation evolving regulatory frameworks and shifting commercial priorities are redefining value creation and competitive positioning in transgenic crop development

The landscape for transgenic crops is shifting in ways that alter competitive dynamics, investment priorities, and adoption pathways. Technological progress in gene editing, trait stacking, and high-throughput phenotyping has accelerated the pace at which actionable traits move from concept to field trials. As a result, companies that integrate molecular innovation with pragmatic breeding strategies and robust field validation are gaining a strategic edge. This technological momentum is complemented by growing operational sophistication among seed companies, which are increasingly combining proprietary traits with enhanced seed treatments and digital agronomy to deliver demonstrable on-farm value.

Simultaneously, regulatory frameworks are evolving to accommodate novel biotechnologies while balancing public acceptance and biosafety concerns. In several jurisdictions, streamlined approval pathways for certain gene-edited events have reduced time to commercialization, prompting a reconsideration of global development strategies. That said, regulatory heterogeneity persists, and firms must design compliant, flexible product portfolios that address divergent approval requirements across key markets.

Market acceptance is also changing as downstream actors-processors, food and feed companies, and farmers-assess the economic and sustainability implications of transgenic adoption. Increasing emphasis on resilience has elevated the importance of traits like drought tolerance, while integrated pest management priorities continue to support insect resistance innovations. Taken together, these transformative shifts are redefining where value is created and captured within the transgenic ecosystem, underscoring the need for cross-functional strategies that bridge science, regulatory affairs, and commercial execution.

Understanding the broad commercial and operational ripple effects of tariff policy changes on transgenic crop supply chains research collaborations and on-farm decision making through 2025

The cumulative effect of tariff policy changes announced and implemented through 2025 has introduced a layer of commercial complexity that suppliers and buyers cannot ignore. Tariff adjustments influence the cost calculus for traded agricultural commodities, seed inputs, and trait licensing across international supply chains. For multinational developers, tariff volatility complicates decisions about where to stage production, conduct field trials, and place inventory, and it affects the pricing strategies necessary to maintain competitiveness in export-focused crop segments.

Trade frictions also have indirect consequences for research and development collaborations. When cross-border exchanges of germplasm, biological materials, or specialized equipment become more expensive or administratively burdensome, project timelines extend and transactional friction increases. In that context, companies are recalibrating partnership models by emphasizing regional hubs for breeding and scaling operations, thereby reducing exposure to tariff-driven cost shocks while preserving access to critical germplasm pools.

From a farmer and processor perspective, tariff-driven changes to input and commodity economics can shift crop rotations and management choices, thereby influencing trait demand. For example, altered import or export incentives for maize, soybean, cotton, or canola change growers' risk-reward calculations and can accelerate or delay adoption of specific transgenic traits. Policymakers and industry leaders must therefore account for both direct tariff impacts and the cascade of behavioral responses that reshape deployment patterns across geographies.

Leveraging nuanced trait crop application and end user segmentation to align research priorities commercialization strategies and stakeholder engagement for transgenic crop initiatives

An effective segmentation-driven approach illuminates where technological advances and commercial demand intersect to create differentiated opportunities. Based on Trait Type, attention centers on Drought Tolerance, Herbicide Tolerance, and Insect Resistance as primary vectors for near-term adoption, each delivering distinct agronomic benefits and influencing breeding priorities. Based on Crop Type, Canola, Cotton, Maize, and Soybean represent crop-specific pathways where trait value propositions, regulatory pathways, and seed system dynamics vary markedly; strategic plans must reflect those crop-specific realities. Based on Application, Biofuel, Food & Feed, Pharmaceutical, and Processing uses define end-market requirements and quality thresholds that shape trait selection, stewardship expectations, and traceability needs. Based on End User, the ecosystem comprises Biotech Companies, Farmers, Government Bodies, Research Institutions, and Seed Companies, each of which exerts unique pressures on commercialization timelines, liability profiles, and adoption incentives.

Interpreting segmentation through a strategic lens reveals that trait-centric investment should align closely with crop economics and application needs. Drought tolerance commands strategic importance where climate variability threatens yield stability, while herbicide tolerance and insect resistance continue to underpin operational efficiencies and pest management strategies. Crop-specific constraints and processing requirements mean that a one-size-fits-all approach to trait development is unlikely to produce sustainable returns. Instead, integrated programs that couple trait innovation with seed performance, stewardship frameworks, and supply chain assurances will unlock broader acceptance.

Moreover, end-user diversity underscores the necessity of cross-sector engagement. Successful deployment depends on engaging farmers to validate agronomic benefits in real-world settings, coordinating with seed companies on distribution and stewardship, partnering with research institutions on long-term trait improvement, and working with government bodies to ensure regulatory alignment and public confidence. By grounding R&D and commercialization plans in these layered segmentation insights, organizations can better allocate resources and tailor messages to the stakeholders most critical to adoption.

Navigating distinct regional opportunities and regulatory realities across the Americas Europe Middle East & Africa and Asia-Pacific to optimize trait development and market entry strategies

Regional dynamics play a decisive role in shaping the trajectory of transgenic crop deployment and the operational choices of industry participants. In the Americas, integrated value chains, significant private-sector breeding capacity, and widespread farmer familiarity with transgenic technologies create fertile conditions for rapid iteration and commercial scaling. This environment supports experimentation with trait stacks and enables commercial entities to validate agronomic claims across diverse agroecological zones.

Europe, Middle East & Africa present a more complex regulatory and social landscape where public perception, diverse regulatory approaches, and heterogeneous infrastructure levels drive differentiated strategies. In some jurisdictions within this region, stringent regulatory requirements and heightened stakeholder scrutiny necessitate a cautious, transparency-focused approach. Meanwhile, parts of Africa and the Middle East represent strategic opportunities for traits that address climate resilience and resource constraints, provided developers invest in public engagement and capacity building.

Asia-Pacific encompasses a broad spectrum of adoption scenarios, from highly commercialized cropping systems to smallholder-dominated landscapes. Regulatory environments and consumer preferences vary widely, influencing product acceptance, stewardship models, and partnership structures. Companies operating in this region increasingly pursue localized breeding programs and public-private partnerships to ensure that transgenic traits address both large-scale commodity demands and localized crop challenges. Across all regions, success depends on tailoring strategies to regulatory realities, supply chain structures, and stakeholder expectations in each geography.

Examining how integrated R&D stewardship partnerships and operational excellence determine competitive advantage in the transgenic crop development ecosystem

Competitive dynamics within the transgenic crop arena are driven by a combination of scientific capability, regulatory expertise, and commercial execution. Leading organizations differentiate themselves by managing the entire innovation lifecycle: from discovery and molecular characterization to multi-location field validation, regulatory submission, and commercial seed multiplication. Partnerships, licensing arrangements, and acquisitions remain important levers for expanding trait portfolios and accelerating time-to-market.

In addition to proprietary trait development, successful companies demonstrate strength in stewardship and supply chain reliability. They invest in data-driven agronomy services, farmer training programs, and post-commercialization monitoring to preserve trait efficacy and manage resistance risks. Firms that integrate molecular R&D with practical extension and commercial support are better positioned to achieve durable adoption and mitigate reputational and regulatory risks.

Research institutions and public sector actors continue to play a critical role, particularly in early-stage discovery and in contexts where public goods such as drought tolerance for smallholder systems are prioritized. Collaborative models that combine private-sector scale with public-sector legitimacy can accelerate adoption while addressing societal concerns. Overall, the competitive landscape rewards vertically integrated capabilities, collaborative agility, and a disciplined approach to regulatory and stewardship obligations.

Mandated strategic actions to synchronize trait development regulatory preparedness supply chain resilience and stewardship efforts for scalable responsible adoption of transgenic crops

Industry leaders should adopt a set of practical actions to translate scientific promise into commercial resilience and societal value. First, align trait development roadmaps with crop-specific agronomic realities and end-market requirements, prioritizing traits that deliver measurable on-farm benefits and resilience under climate variability. Second, build regulatory strategies that anticipate heterogeneity across jurisdictions by investing in modular data packages, adaptive trial designs, and proactive engagement with regulators and civil society stakeholders.

Third, strengthen supply chain resilience by establishing regional breeding hubs, local seed multiplication capacity, and redundant logistics to mitigate tariff or trade disruptions. Fourth, commit to robust stewardship programs that combine resistance management, farmer training, and post-market surveillance to maintain trait efficacy and public trust. Fifth, pursue collaborative models that leverage public research strengths alongside private-sector commercialization capacity to address challenges in smallholder contexts and to broaden social legitimacy.

Finally, invest in transparent communication strategies that articulate the agronomic, environmental, and economic rationale for transgenic solutions while openly addressing safety and stewardship concerns. By executing these actions in concert, leaders can reduce commercialization friction, accelerate adoption where appropriate, and align transgenic crop innovations with broader sustainability and food security goals.

Methodological approach that integrates primary expert interviews secondary literature regulatory review and value chain analysis to ensure rigorous evidence-based conclusions

This research synthesizes peer-reviewed scientific literature, regulatory filings, public policy documents, and primary qualitative interviews with expert stakeholders to construct a robust and defensible analytical foundation. The methodology emphasizes triangulation across multiple data sources and validation through expert consultation to ensure that interpretations reflect both technological realities and commercial constraints. Field trial reports, patent landscapes, and scientific conference disclosures were reviewed to assess the maturity of key trait categories and to identify emergent technical capabilities.

Primary research included structured interviews with senior R&D leaders, regulatory specialists, seed company executives, and academic researchers to capture diverse perspectives on adoption barriers, stewardship practices, and strategic responses to trade dynamics. Secondary research encompassed regulatory agency communications, industry association statements, and widely accepted scientific syntheses to contextualize primary findings. Analytical frameworks applied in the study include value chain mapping, stakeholder analysis, and scenario-based impact assessment to explore how variables such as tariff shifts and regional regulatory divergence influence strategic choices.

Throughout the research process, attention was paid to methodological transparency and to documenting assumptions that underpin qualitative inferences. Where uncertainty persists, the analysis highlights contingency considerations and recommends targeted follow-up studies to refine understanding in rapidly evolving areas such as gene-editing policy and cross-border germplasm flows.

Concluding synthesis on aligning scientific innovation regulatory compliance stewardship and stakeholder engagement to realize the potential of transgenic crops responsibly

In summary, transgenic crop technologies stand at a strategic inflection point where scientific capability, regulatory evolution, and commercial imperatives converge. The path forward requires integrated strategies that link trait innovation to crop-specific realities, application demands, and end-user expectations. While technological progress lowers technical barriers to developing valuable traits, heterogeneity in regulatory regimes and recent trade policy shifts complicate the operational landscape and necessitate adaptive commercialization roadmaps.

Organizations that succeed will combine scientific excellence with pragmatic regulatory planning, resilient supply chain design, and transparent stewardship. Cross-sector collaboration remains essential for addressing societal concerns, accelerating adaptive breeding in response to climate pressures, and ensuring that benefits reach diverse farming systems. Ultimately, the responsible advancement of transgenic crops hinges on aligning innovation with clear agronomic value, regulatory compliance, and stakeholder trust, thereby enabling these technologies to contribute meaningfully to sustainable agricultural outcomes.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Integration of RNA interference techniques for targeted insect pest suppression in cotton
• 5.2. Adoption of herbicide tolerant soybean lines with stacked tolerance traits for weed management
• 5.3. Commercialization of biofortified rice varieties enriched with provitamin A to address malnutrition
• 5.4. Application of gene drive systems to control invasive pest populations in staple crops
• 5.5. Deployment of glyphosate and glufosinate dual-tolerant canola lines to improve yield stability
• 5.6. Implementation of next generation sequencing for regulatory approval of novel transgenic crops

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Agricultural Biotechnology for Transgenic Crops Market, by Trait Type

• 8.1. Drought Tolerance
• 8.2. Herbicide Tolerance
• 8.3. Insect Resistance

9. Agricultural Biotechnology for Transgenic Crops Market, by Crop Type

• 9.1. Canola
• 9.2. Cotton
• 9.3. Maize
• 9.4. Soybean

10. Agricultural Biotechnology for Transgenic Crops Market, by Application

• 10.1. Biofuel
• 10.2. Food & Feed
• 10.3. Pharmaceutical
• 10.4. Processing

11. Agricultural Biotechnology for Transgenic Crops Market, by End User

• 11.1. Biotech Companies
• 11.2. Farmers
• 11.3. Government Bodies
• 11.4. Research Institutions
• 11.5. Seed Companies

12. Agricultural Biotechnology for Transgenic Crops Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Agricultural Biotechnology for Transgenic Crops Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Agricultural Biotechnology for Transgenic Crops Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. Bayer AG
  • 15.3.2. Corteva, Inc.
  • 15.3.3. Syngenta AG
  • 15.3.4. BASF SE
  • 15.3.5. KWS SAAT SE & Co. KGaA
  • 15.3.6. Groupe Limagrain
  • 15.3.7. Land O'Lakes, Inc.
  • 15.3.8. Bioceres Crop Solutions Corp
  • 15.3.9. Arcadia Biosciences, Inc.
  • 15.3.10. Evogene Ltd

LIST OF FIGURES

• FIGURE 1. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 11. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 28. AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY INSECT RESISTANCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY INSECT RESISTANCE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY INSECT RESISTANCE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY INSECT RESISTANCE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY INSECT RESISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY INSECT RESISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CANOLA, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CANOLA, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CANOLA, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CANOLA, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CANOLA, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CANOLA, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COTTON, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COTTON, BY REGION, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COTTON, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COTTON, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COTTON, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COTTON, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY MAIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY MAIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY MAIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY MAIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY MAIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY MAIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SOYBEAN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SOYBEAN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SOYBEAN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SOYBEAN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOFUEL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOFUEL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOFUEL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOFUEL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOFUEL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOFUEL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FOOD & FEED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FOOD & FEED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FOOD & FEED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FOOD & FEED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FOOD & FEED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FOOD & FEED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PROCESSING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PROCESSING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FARMERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FARMERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FARMERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FARMERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FARMERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FARMERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GOVERNMENT BODIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GOVERNMENT BODIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GOVERNMENT BODIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GOVERNMENT BODIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GOVERNMENT BODIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GOVERNMENT BODIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SEED COMPANIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SEED COMPANIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SEED COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SEED COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SEED COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SEED COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 112. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 113. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 114. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 115. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 116. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
• TABLE 117. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 118. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 119. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 120. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 121. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 122. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 123. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 124. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 125. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 126. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
• TABLE 127. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 128. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 129. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 130. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 131. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 132. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 133. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 134. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 135. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 136. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
• TABLE 137. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 138. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 139. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 140. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 141. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 142. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 143. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 144. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 145. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 151. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 152. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 153. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 154. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 155. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 156. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
• TABLE 157. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 158. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 159. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 160. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 161. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 162. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 163. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 164. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 165. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 166. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
• TABLE 167. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 168. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 169. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 170. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 171. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 172. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 173. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 174. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 175. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 176. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
• TABLE 177. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 178. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 179. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 180. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 181. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 182. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 183. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 184. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 185. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 186. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
• TABLE 187. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 188. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 189. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 190. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 193. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 194. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 195. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 196. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 197. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 198. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
• TABLE 199. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 200. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 201. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 202. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 203. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 204. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 205. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 206. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 207. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 208. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
• TABLE 209. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 210. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 211. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 212. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 213. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 214. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 215. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 216. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 217. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 218. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
• TABLE 219. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 220. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 221. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 222. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 223. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 224. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 225. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 226. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 227. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 228. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
• TABLE 229. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 230. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 231. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 232. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 233. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 234. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 235. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 236. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 237. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 238. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
• TABLE 239. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 240. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 241. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 242. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 243. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 244. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 245. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 246. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 247. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 248. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
• TABLE 249. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 250. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 251. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 252. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 253. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 254. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 255. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 256. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 257. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 258. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
• TABLE 259. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 260. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 261. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 262. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 263. CANADA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
• TABLE 264. CANADA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
• TABLE 265. CANADA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
• TABLE 266. CANADA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (U